INVITRO SUSCEPTIBILITY OF BRUCELLA-MELITENSIS TO ANTIBIOTICS

被引：46

作者：

RUBINSTEIN, E ^{[1
]}

LANG, R ^{[1
]}

SHASHA, B ^{[1
]}

HAGAR, B ^{[1
]}

DIAMANSTEIN, L ^{[1
]}

JOSEPH, G ^{[1
]}

ANDERSON, M ^{[1
]}

HARRISON, K ^{[1
]}

机构：

[1] TEL AVIV UNIV,SCH MED,IL-69978 TEL AVIV,ISRAEL

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1991年 / 35卷 / 09期

关键词：

D O I：

10.1128/AAC.35.9.1925

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The in vitro susceptibilities of 86 recent clinical isolates of Brucella melitensis to minocycline, streptomycin, co-trimoxazole, rifampin, and six fluoroquinolones were determined. Minocycline exhibited the lowest MIC and was followed by rifampin and streptomycin. Among the quinolones, WIN 57273 and ciprofloxacin were the most active agents. No antibiotic combination of these agents exhibited synergy against 15 selected isolates. In killing rate experiments, streptomycin exhibited the most rapid kill (< 12 h), while a complete kill with minocycline, rifampin, and ciprofloxacin was delayed up to 48 h. The combinations of streptomycin with each of minocycline, rifampin, or ciprofloxacin exhibited the fastest kills (within 2 h), while with the other combinations, a complete kill was delayed up to 96 h. These results demonstrate the discrepancy between the results of various in vitro methods in evaluating the antibiotic susceptibility of B. melitensis.

引用

页码：1925 / 1927

页数：3

共 17 条

[1]

ALSIBAI MB, 1989, 29TH INT C ANT AG CH

[2] INVITRO ACTIVITY OF N-FORMIMIDOYL THIENAMYCIN AGAINST 98 CLINICAL ISOLATES OF BRUCELLA-MELITENSIS COMPARED WITH THOSE OF CEFOXITIN, RIFAMPIN, TETRACYCLINE, AND CO-TRIMOXAZOLE [J].